Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

The high cost of EP mapping and ablation catheters consumes about 60 percent of CMS reimbursement for atrial fibrillation catheter ablation procedures. This has led some hospitals to start reprocessing the catheters to cut costs.
Blog | Cardiovascular Business
Integrating Cath and EP Lab Reprocessing With OM Technology Development
With all eyes on rising healthcare costs, reprocessing of single-use devices has become an increasingly important ...
Home December 23, 2019
Home
Videos | Radiation Dose Management
VIDEO: Radiation From Medical Imaging in U.S. Dropped Over Past Decade

 


Mahadevappa Mahesh, Ph.D., chief of medical physicist and professor of radiology and medical physics, Johns Hopkins ...

Home December 19, 2019
Home
Videos | RSNA
VIDEO: Key Medical Imaging Technology Trends at the 2019 RSNA

DAIC Editor Dave Fornell and Imaging Technology News (ITN) Consulting Editor Greg Freiherr offer a post-game report on ...

Home December 18, 2019
Home
News | Cath Lab
Cook Medical Recalls CrossCath Support Catheters Due to Marker Bands Dislodging

December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S. Food ...

Home December 18, 2019
Home
The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital. Photo by Scott Morgan/AHA.
Feature
Most Popular Cardiology Technology Content in November 2019

December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home December 17, 2019
Home
Vascepa pill contains a concentrated form of fish oil, icosapent ethyl, indication for prevention. The U.S. Food and Drug Administration (FDA) Dec. 13, 2019, approved the use of Vascepa (icosapent ethyl) capsules as an adjunctive therapy to reduce the risk of cardiovascular events in adults with elevated triglyceride levels.
Feature | Pharmaceuticals | Dave Fornell, Editor
FDA Expands Vascepa to Reduce Cardiovascular Events in Elevated Triglyceride Patients

December 16, 2019 — The U.S. Food and Drug Administration (FDA), on Dec. 13, approved the use of Vascepa (icosapent ...

Home December 16, 2019
Home
CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and medical imaging companies for the first time at the Radiological Society of North America (RSNA) 2019 meeting. With technology platforms that integrate modeled human physiology into immersive, augmented reality environments, CAE Healthcare partners with vendors to deliver risk-free training solutions that meet the needs of physicians and equipment providers. #RSNA19 #RSNA2019
News | Virtual and Augmented Reality
Augmented Reality for Radiology and Cardiology Training Demonstrated at RSNA 2019

November 27, 2019 — CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and ...

Home November 27, 2019
Home
A sample of the transcatheter mitral valve replacement (TMVR) devices in development or clinical trials.
Feature | Heart Valve Technology | Saipriya Iyer
Developments in Transcatheter Mitral Valve Replacement

The overwhelming success story for transcatheter aortic valve replacement (TAVR) moving from a science project to ...

Home November 27, 2019
Home
A key slide from the TRILUMINATE study one-year results showing the improvement in tricuspid regurgitation from basement with treatment using the transcatheter TriClip device.
News | Heart Valve Technology | Dave Fornell, Editor
TriClip Device For Tricuspid Regurgitation Effective at One Year in TRILUMINATE Study

November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a ...

Home November 26, 2019
Home
The FDA cleared the IN.PACT AV drug-coated Balloon. Clinical data shows In.Pact AV DCB is Safe, reduces reinterventions and maintains access for end-stage renal disease patients undergoing dialysis
News
FDA Clears Medtronic Drug-Coated Balloon to Treat Arteriovenous Fistula Lesions

November 21, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic In.Pact AV drug-coated balloon ...

Home November 26, 2019
Home
The percentage of women entering the cardiology workforce is low, despite the fact that half of all medical students are women. Despite the low numbers, many women have become luminaries in the field of cardiology, including Dee Dee Wang, M.D., director of advanced cardiovascular imaging at Henry Ford Hospital, pictured here.
Blog | Cardiovascular Business
Women: Cardiology Needs You!

Now, more than ever, the field of cardiology needs women. 


But as the national need for more cardiologists overall ...

Home November 22, 2019
Home
The three sites most often used for distal radial artery access are the (1) anatomic snuffbox above the scaphoid (left), (2) adjacent to the snuffbox at the trapezium bone (center), and (3) the first intermetacarpal space (right). The author’s preference is either of the first two options, although good outcomes have been reported with use of the intermetacarpal space.
Feature | Radial Access | Enrique Flores, M.D., RPVI
Incorporating Distal Radial Artery Access Into Clinical Practice
Interest in distal radial artery access (DRA) is growing rapidly. Among the benefits of DRA are the low risk of entry ...
Home November 21, 2019
Home
In the ISCHEMIA study, patients were randomized into one of two groups: a conservative strategy or an invasive strategy. Illustration by NYU Langone staff
Feature | AHA
ISCHEMIA Trial Results Find Interventions for Stable Heart Disease No better Than Drug Therapy

November 19, 2019 — After 12 years of collecting data, the results of the landmark ISCHEMIA (International Study of ...

Home November 19, 2019
Home
Since Maquet/Datascope first recalled all of its intra-aortic balloon pumps (IABP) due to reports of the batteries failing in November 2018, a year later the U.S. Food and Drug Administration said its has received more than 60 additional medical device reports related to this issue. These included two patient deaths and one serious patient injury.
News
Over 60 New Safety Reports Filed With FDA for Maquet IABPs Turning Off During Use

November 19, 2019 — Since Maquet/Datascope first recalled all of its  intra-aortic balloon pumps (IABP) due to reports ...

Home November 19, 2019
Home
The American Heart Association, AHA, 2019 meeting late breaking trials and key studies on cardiovascular science.
Feature | AHA | Dave Fornell, Editor
American Heart Association 2019 Late-breaking Trials

November 19, 2019 — Here is a list of the key late-breaking clinical study presentations and links to the results at the ...

Home November 19, 2019
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now